NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/02/2026
Back to search
Official data from USPTO
MAGLUMI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
07/17/2013
Registration date
02/10/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
Shenzhen, Guangdong, CN
Examiner
BRADLEY, EVELYN
Current location
Historical data usage
Mark description
The mark consists of the stylized words "MAGLUMI".
Holders and representatives
Holders
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Representatives
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugs for medical purposes for treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin disease; medicated serums for invitro diagnosis and treatment; medicated serums for in-vivo diagnosis and treatment; serotherapeutic medicines; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; chemical preparations for pharmaceutical purposesfor diagnosis or treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposesfor diagnosing or detecting tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy
Class 10
Blood testing apparatus; massage apparatus; apparatus for use in medical analysismedical analyzer for analysis of blood samplesbody fluids and body tissue samples; testing apparatus for medical purposesmedical testing instrument for testing blood samplesbody fluids and body tissue samples; diagnostic apparatus for medical purposesmedical diagnostic analyzer for analyzing blood samplesbody fluids and body tissue samples; radiotherapy apparatus; ultrasonic devices and parts thereof for medical useclinical ultrasonic diagnostic apparatus and parts thereof ; artificial limbs; multifunction corsets for medical purposediagnosis and therapeutic corsets for medical purpose; suture materials
Publications
History of USPTO decisions and trademark events.
58 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/19/2026
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/19/2025
71AG
REGISTERED-SEC.71 ACCEPTED
05/19/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/19/2025
ES71
TEAS SECTION 71 RECEIVED
01/24/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/10/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/12/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/12/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/22/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
02/22/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/02/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/02/2022
71AG
REGISTERED-SEC.71 ACCEPTED
05/02/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11/19/2021
PR71
POST REGISTRATION ACTION MAILED - SEC.71
10/27/2021
PR71
POST REGISTRATION ACTION MAILED - SEC.71
10/25/2021
REIN
REINSTATED
10/25/2021
NC71
NOTICE OF CANCELLATION SEC. 71 E-MAILED
10/16/2021
C71T
CANCELLED SECTION 71
10/15/2021
PR71
POST REGISTRATION ACTION MAILED - SEC.71
03/11/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/04/2021
ES71
TEAS SECTION 71 RECEIVED
02/07/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/20/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/26/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/27/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/11/2015
FIMP
FINAL DISPOSITION PROCESSED
06/11/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/10/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2015
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/13/2015
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/03/2015
PUBO
PUBLISHED FOR OPPOSITION
11/25/2014
NPUB
NOTICE OF PUBLICATION
11/05/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/23/2014
CNEA
EXAMINERS AMENDMENT MAILED
10/22/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/22/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
10/22/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/22/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/13/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/13/2014
CNFR
FINAL REFUSAL MAILED
05/27/2014
CNFR
FINAL REFUSAL WRITTEN
05/26/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/17/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/17/2014
ALIE
ASSIGNED TO LIE
04/08/2014
ALIE
ASSIGNED TO LIE
03/28/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/17/2014
RFNT
REFUSAL PROCESSED BY IB
01/17/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/30/2013
RFRR
REFUSAL PROCESSED BY MPU
12/30/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/21/2013
CNRT
NON-FINAL ACTION WRITTEN
12/20/2013
MAFR
APPLICATION FILING RECEIPT MAILED
12/18/2013
DOCK
ASSIGNED TO EXAMINER
12/14/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2013
Continuous trademark protection
Get notified about every new filing that threatens MAGLUMI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.